Shorter scan, same accuracy? new prostate cancer test aims to cut costs and time
NCT ID NCT05046782
Summary
This study aimed to test a shorter, less expensive type of MRI scan for detecting prostate cancer. The goal was to see if this new scan, which doesn't use contrast dye, could find cancer as accurately as the standard, longer MRI. The study was designed for men with confirmed prostate cancer who were scheduled for surgery or a targeted biopsy. However, the trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.